A Structure-Based Drug Design Approach for the Identification of Novel Selective Cyclooxygenase-2 Inhibitors using Resveratrol Analogues as Lead Molecules.Published in:Biomirror, 2015, v. 6, n. 10, p. 100By:Caruana, Clarissa;Shoemake, ClairePublication type:Article